NCT02868372

Brief Summary

The study has 2 groups. Group A in which the subcutaneous tissue will be swabbed with 10 cc of undiluted 10% povidone iodine and will not be mobbed. Group B ; No swabbing. Women in both groups will be followed up during hospital stay and outpatient clinic visits a week and a month after cesarean delivery for surgical site complications which will be evaluated by the researcher.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
538

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2016

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2016

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 16, 2016

Completed
16 days until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

August 16, 2016

Status Verified

August 1, 2016

Enrollment Period

6 months

First QC Date

July 29, 2016

Last Update Submit

August 14, 2016

Conditions

Keywords

Cesarean sectionBetadineWound infection

Outcome Measures

Primary Outcomes (1)

  • Detect and record the incidence of surgical wound infection in both groups

    : Women in both groups will be followed up during hospital stay and outpatient clinic visit for one month after cesarean delivery for surgical site complications which will be evaluated by the researcher

    One month

Study Arms (2)

Betadine group

ACTIVE COMPARATOR

Subcutaneous tissues of cesarean section wounds are swabbed with10% undiluted Povidone Iodine solution without mobbing before closure of subcutaneous tissues

Drug: Povidone iodine

No intervention group

NO INTERVENTION

No swabbing of subcutaneous tissue of cesarean section wounds

Interventions

After closure of the anterior wall of the rectus sheath, the subcutaneous tissues of the cesarean section wound will be swabbed with 10% undiluted Povidone iodine without mobbing.

Also known as: Betadine
Betadine group

Eligibility Criteria

Age20 Years - 43 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All women having either first time or repeat cesarean section whether elective or emergency.

You may not qualify if:

  • Women with prolonged rupture of membranes more than 12 hours.
  • Women with morbid obesity with BMI\>35.
  • Women with diabetes, hypertension or anemia with hemoglobin\<9.
  • Women on corticosteroid therapy or immunosuppressed women.
  • Women with intraoperative hemorrhage or hematoma formation.
  • Women allergic to betadine.
  • The cesarean section which duration exceed one hour or associated with other surgical procedure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Wound Infection

Interventions

Povidone-Iodine

Condition Hierarchy (Ancestors)

Infections

Intervention Hierarchy (Ancestors)

IodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, OB-GYN department- Principal investigator

Study Record Dates

First Submitted

July 29, 2016

First Posted

August 16, 2016

Study Start

September 1, 2016

Primary Completion

March 1, 2017

Study Completion

April 1, 2017

Last Updated

August 16, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share